Conditions chroniques associées aux infections (CCAI)

Description

COVID longue

Lignes directrices canadiennes

Mise à jour du 17 juillet 2025

Mise à jour du 31 mars 2025

Mise à jour du 5 mars 2025

Nouvelles publications scientifiques

ccai_covid_longue via biblio.chum on Inoreader

The fatigue spectrum in a community-based long haul COVID cohort
on 6 février 2026
Sleep Breath. 2026 Jan 31;30(1):27. doi: 10.1007/s11325-025-03512-y.ABSTRACTINTRODUCTION: In a Long Haul COVID referral clinic we describe the primary presentations of fatigue according to the CDC […]
Long COVID Between People With and Without HIV: a Statewide Cohort Analysis
on 6 février 2026
J Acquir Immune Defic Syndr. 2026 Feb 4. doi: 10.1097/QAI.0000000000003840. Online ahead of print.ABSTRACTBACKGROUND: This study aims to compare the risks of a panel of long COVID manifestations […]
A digital platform with activity tracking for energy management support in long COVID: a randomised controlled trial
on 6 février 2026
Nat Commun. 2026 Feb 2;17(1):945. doi: 10.1038/s41467-025-64831-y.ABSTRACTIn a 6-month pragmatic randomised controlled trial (RCT; ISRCTN16033549), we compared a just-in-time intervention to support […]
Clinical features and inflammatory signatures of patients with persistent gastrointestinal long COVID two years after severe SARS-CoV-2 infection
on 6 février 2026
Sci Rep. 2026 Jan 29. doi: 10.1038/s41598-026-37595-8. Online ahead of print.NO ABSTRACTPMID:41611926 | DOI:10.1038/s41598-026-37595-8
Ethnic Differences in Symptom Burden, Work and Daily Life: A Study of Long COVID Patients in Denmark
on 6 février 2026
J Gen Intern Med. 2026 Jan 29. doi: 10.1007/s11606-026-10214-y. Online ahead of print.ABSTRACTBACKGROUND: Ethnic minorities appear to be at higher risk of long COVID. Our objective was to estimate […]
Preventing Long COVID With Metformin
on 6 février 2026
Clin Infect Dis. 2026 Jan 29:ciaf700. doi: 10.1093/cid/ciaf700. Online ahead of print.NO ABSTRACTPMID:41608911 | DOI:10.1093/cid/ciaf700
Depressive and anxiety symptoms in individuals with Long-COVID: Does social network matter? - Results of a German Long-COVID study
on 6 février 2026
J Affect Disord. 2026 Jan 26:121272. doi: 10.1016/j.jad.2026.121272. Online ahead of print.ABSTRACTBACKGROUND: Some patients previously infected with SARS-CoV-2 develop symptoms that are summarized […]
Rehabilitation needs of long COVID patients in British Columbia
on 6 février 2026
PM R. 2026 Jan 28. doi: 10.1002/pmrj.70092. Online ahead of print.ABSTRACTINTRODUCTION: COVID-19 can result in persistent symptoms and functional impairment that significantly impact daily […]
Early administration of neutralising monoclonal antibodies and post-acute sequelae of COVID-19
on 6 février 2026
Int J Infect Dis. 2026 Jan 25:108435. doi: 10.1016/j.ijid.2026.108435. Online ahead of print.ABSTRACTOBJECTIVES: Post-acute sequelae of COVID-19 (PASC) are more common in unvaccinated or […]
Interpretable machine learning for predicting low-dose methylprednisolone effectiveness in long COVID
on 6 février 2026
iScience. 2025 Dec 30;29(2):114574. doi: 10.1016/j.isci.2025.114574. eCollection 2026 Feb 20.ABSTRACTLong COVID is a chronic, multisystem disease with limited response to conventional treatments. […]
Activation of the Lectin Pathway Drives Persistent Complement Dysregulation in Long COVID
on 6 février 2026
Immunology. 2026 Jan 25. doi: 10.1111/imm.70110. Online ahead of print.ABSTRACTLong COVID affects a substantial proportion of survivors of acute infection with severe acute respiratory […]
Shared autonomic phenotype of long COVID and myalgic encephalomyelitis/chronic fatigue syndrome
on 6 février 2026
PLoS One. 2026 Jan 23;21(1):e0341278. doi: 10.1371/journal.pone.0341278. eCollection 2026.ABSTRACTINTRODUCTION: Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are […]
Characterizing Neuro-PASC outcome with the mobile Neuro-COVID recovery care companion application
on 6 février 2026
BMC Neurol. 2026 Jan 12;26(1):24. doi: 10.1186/s12883-025-04577-8.ABSTRACTBACKGROUND: Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), affects 14 million people in the US. […]
Social Determinants of Health and Pediatric Long COVID in the US
on 9 janvier 2026
JAMA Pediatr. 2026 Jan 5. doi: 10.1001/jamapediatrics.2025.5485. Online ahead of print.ABSTRACTIMPORTANCE: Millions of children worldwide are experiencing prolonged symptoms after SARS-CoV-2 […]
Neurological symptoms and physical exam findings 6-11 months post-COVID-19: a cohort study
on 9 janvier 2026
Sci Rep. 2026 Jan 2. doi: 10.1038/s41598-025-33779-w. Online ahead of print.NO ABSTRACTPMID:41484407 | DOI:10.1038/s41598-025-33779-w
Long Covid Syndrome and Role of Autonomic Nervous System
on 9 janvier 2026
Rev Med Virol. 2026 Jan;36(1):e70101. doi: 10.1002/rmv.70101.NO ABSTRACTPMID:41474066 | DOI:10.1002/rmv.70101
Patient perspectives on the usability and content validity of the assessment of burden of chronic conditions tool for post-COVID in the Netherlands: a qualitative study
on 9 janvier 2026
BMJ Open. 2025 Dec 12;15(12):e109201. doi: 10.1136/bmjopen-2025-109201.ABSTRACTBACKGROUND: Post-COVID syndrome manifests with a diverse array of symptoms for which no standard care plan currently […]
Long COVID involves activation of proinflammatory and immune exhaustion pathways
on 9 janvier 2026
Nat Immunol. 2025 Dec 12. doi: 10.1038/s41590-025-02353-x. Online ahead of print.ABSTRACTLong COVID (LC) involves a spectrum of chronic symptoms after acute severe acute respiratory syndrome […]
PCE-CfD and Long Covid: An NHS Service Evaluation on the Benefits of Using Person-Centred Experiential Counselling for Depression With People With Long Covid
on 9 janvier 2026
Health Expect. 2025 Dec;28(6):e70517. doi: 10.1111/hex.70517.ABSTRACTBACKGROUND: Long Covid is a condition affecting multiple organ systems and the mental health of patients. To address this, two […]
Long covid pulmonary rehabilitation
on 9 janvier 2026
Rev Mal Respir. 2025 Dec 16:S0761-8425(25)00265-7. doi: 10.1016/j.rmr.2025.12.001. Online ahead of print.ABSTRACTWhile the SARS-CoV-2 pandemic has left a lasting impression, the long-term effects of […]

Maladie de Lyme

ccai_lyme via biblio.chum on Inoreader

Lyme Disease and Health Care Costs
on 6 février 2026
JAMA Netw Open. 2026 Jan 2;9(1):e2552518. doi: 10.1001/jamanetworkopen.2025.52518.ABSTRACTIMPORTANCE: Lyme disease (LD) is the most common vector-borne illness in the US. Given the increasing […]
Deficiencies in communication between clinical microbiological laboratories and physicians may impair the diagnosis of Lyme borreliosis: A study of the use and application of serology in three neighbouring counties in Sweden
on 6 février 2026
PLoS One. 2025 Dec 26;20(12):e0339449. doi: 10.1371/journal.pone.0339449. eCollection 2025.ABSTRACTPURPOSE: The diagnosis of Lyme borreliosis (LB) can be challenging. The aim of this study was to […]
A human Lyme disease vaccine: two steps forward on the path to prevention
on 6 février 2026
Expert Rev Vaccines. 2026 Dec;25(1):2607482. doi: 10.1080/14760584.2025.2607482. Epub 2025 Dec 25.ABSTRACTINTRODUCTION: Lyme disease is caused by the tick-borne spirochete pathogen Borrelia […]
Deficiencies in communication between clinical microbiological laboratories and physicians may impair the diagnosis of Lyme borreliosis: A study of the use and application of serology in three neighbouring counties in Sweden
on 9 janvier 2026
PLoS One. 2025 Dec 26;20(12):e0339449. doi: 10.1371/journal.pone.0339449. eCollection 2025.ABSTRACTPURPOSE: The diagnosis of Lyme borreliosis (LB) can be challenging. The aim of this study was to […]
Early brain changes in Lyme disease are associated with clinical outcomes
on 9 janvier 2026
Brain Behav Immun Health. 2025 Dec 2;50:101153. doi: 10.1016/j.bbih.2025.101153. eCollection 2025 Dec.ABSTRACTIn Lyme disease (LD), 10-20 % of patients develop persistent symptoms following […]
A human Lyme disease vaccine: two steps forward on the path to prevention
on 9 janvier 2026
Expert Rev Vaccines. 2025 Dec 21:2607482. doi: 10.1080/14760584.2025.2607482. Online ahead of print.ABSTRACTINTRODUCTION: Lyme disease is caused by the tick-borne spirochete pathogen Borrelia […]
Guidelines for Lyme borreliosis: treatment
on 9 janvier 2026
Infect Dis Now. 2025 Dec;55(8S):105204. doi: 10.1016/j.idnow.2025.105204. Epub 2025 Nov 26.ABSTRACTThe aim of the clinical practice guideline is to support healthcare professionals in the diagnosis […]
Guidelines for Lyme borreliosis: clinical manifestations
on 9 janvier 2026
Infect Dis Now. 2025 Dec;55(8S):105202. doi: 10.1016/j.idnow.2025.105202. Epub 2025 Nov 28.ABSTRACTLyme borreliosis (LB) is a tick-borne zoonosis caused by spirochetes belonging to the Borrelia […]
Guidelines for Lyme borreliosis: Diagnostic strategies
on 9 janvier 2026
Infect Dis Now. 2025 Dec;55(8S):105203. doi: 10.1016/j.idnow.2025.105203. Epub 2025 Nov 26.ABSTRACTThe diagnosis of Lyme borreliosis (LB) relies primarily on clinical evaluation supported by […]
Quantifying the Public Health Impact of Lyme Disease in Minnesota: A Simulation Analysis of Reported and Unreported Cases
on 5 Décembre 2025
J Health Econ Outcomes Res. 2025 Nov 20;12(2):221-228. doi: 10.36469/001c.146618. eCollection 2025.ABSTRACTBackground: Lyme disease, the most common vector-borne disease in Minnesota, is estimated to […]
Polyvalent mRNA vaccine targeting outer surface protein C affords multi-strain protection against Lyme disease
on 5 Décembre 2025
NPJ Vaccines. 2025 Dec 4. doi: 10.1038/s41541-025-01326-3. Online ahead of print.ABSTRACTThere is currently no Lyme disease (LD) vaccine available for use in humans. Outer surface protein C (OspC) of […]
Genetic landscape of Borrelia burgdorferi sensu stricto in Canada: a study of genetic diversity
on 5 Décembre 2025
Sci Rep. 2025 Nov 20;15(1):40954. doi: 10.1038/s41598-025-24758-2.ABSTRACTBorrelia burgdorferi sensu stricto (s.s.), the causative agent of Lyme disease in North America, exhibits considerable […]
Guidelines for Lyme borreliosis: post-treatment Lyme disease syndrome (PTLDS)
on 5 Décembre 2025
Infect Dis Now. 2025 Nov 26:105205. doi: 10.1016/j.idnow.2025.105205. Online ahead of print.ABSTRACTPersistent symptoms following appropriate treatment of confirmed Lyme borreliosis (LB) require a […]
Risk Factors for Lyme Disease in the General Population-A Survey of Adults and Caregivers in 28 States
on 5 Décembre 2025
Open Forum Infect Dis. 2025 Oct 21;12(11):ofaf658. doi: 10.1093/ofid/ofaf658. eCollection 2025 Nov.ABSTRACTBACKGROUND: There are an estimated 476 000 diagnosed and treated cases of Lyme disease (LD) […]
Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosis
on 7 novembre 2025
Ger Med Sci. 2025 Oct 9;23:Doc13. doi: 10.3205/000349. eCollection 2025.ABSTRACTLyme disease is the most common tick-borne infectious disease in Europe. Neurological manifestations occur in 3-15% of […]
Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society
on 7 novembre 2025
Ger Med Sci. 2025 Oct 9;23:Doc12. doi: 10.3205/000348. eCollection 2025.ABSTRACTThe current S2k guideline "kutane Borreliose" has been updated in accordance with the methodological standards of the […]
Identification of potential biomarkers for Lyme disease using bioinformatics and machine learning
on 7 novembre 2025
Clin Exp Med. 2025 Oct 31;25(1):341. doi: 10.1007/s10238-025-01803-y.ABSTRACTLyme disease (LD) presents significant diagnostic challenges due to the absence of a reliable screening method for initial […]
The diagnostic potential of proteomics and machine learning in Lyme neuroborreliosis
on 7 novembre 2025
Nat Commun. 2025 Oct 27;16(1):9322. doi: 10.1038/s41467-025-64903-z.ABSTRACTLyme neuroborreliosis (LNB), a nervous system infection caused by tick-borne spirochetes of the Borrelia burgdorferi sensu […]
Late Lyme neuroborreliosis encephalomyelitis with distinct MRI features-a case report and systematic literature review
on 7 novembre 2025
J Neurol. 2025 Oct 26;272(11):729. doi: 10.1007/s00415-025-13475-5.ABSTRACTBACKGROUND: Central nervous system (CNS) Lyme neuroborreliosis (LNB) rarely occurs. Clinical and radiological findings are […]
Targeted volume imaging reveals early vascular interactions of Lyme disease pathogen in skin
on 7 novembre 2025
Nat Commun. 2025 Oct 22;16(1):9330. doi: 10.1038/s41467-025-64326-w.ABSTRACTAlthough the contours of the dissemination pathways of human pathogenic spirochetes in the vertebrate hosts are known, […]

Encéphalomyélite myalgique

ccai_encephalomyelite via biblio.chum on Inoreader

Indistinguishable mitochondrial phenotypes after exposure of healthy myoblasts to myalgic encephalomyelitis/chronic fatigue syndrome or control serum
on 6 février 2026
PLoS One. 2026 Feb 3;21(2):e0341334. doi: 10.1371/journal.pone.0341334. eCollection 2026.ABSTRACTMyalgic Encephalomyelitis (ME) / Chronic Fatigue Syndrome is a disease of uncertain aetiology that […]
Chronic Fatigue Syndrome Induced by Environmental Toxic Exposure: Effects of Polyhexamethyleneguanidine Phosphate Exposure on Mitochondrial Function and Neural Health
on 6 février 2026
Environ Res. 2026 Jan 27:123874. doi: 10.1016/j.envres.2026.123874. Online ahead of print.ABSTRACTLarge-scale human casualties have been reported following exposure to humidifier disinfectants (HDs), […]
Associations between heart rate and physical activity in people with post-COVID-19 condition accounting for myalgic encephalomyelitis/chronic fatigue syndrome symptoms
on 6 février 2026
J Rehabil Med. 2026 Jan 27;58:jrm43340. doi: 10.2340/jrm.v58.43340.ABSTRACTBACKGROUND: Tachycardia after mild activity or during rest is a common complaint among people with post-COVID-19 condition […]
Tuina therapy for patients with chronic fatigue syndrome: a randomized controlled trial
on 9 janvier 2026
J Transl Med. 2026 Jan 8. doi: 10.1186/s12967-025-07624-7. Online ahead of print.ABSTRACTBACKGROUND: Chronic fatigue syndrome (CFS) is a complex and disabling disorder characterized by persistent […]
Multi-omics identifies lipid accumulation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome cell lines: a case-control study
on 9 janvier 2026
J Transl Med. 2026 Jan 8. doi: 10.1186/s12967-025-07620-x. Online ahead of print.ABSTRACTBACKGROUND: In recent years, evidence has indicated a metabolic shift towards increased demand for lipids in […]
Evaluating working memory functioning in individuals with myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review and meta-analysis
on 9 janvier 2026
Psychol Health Med. 2026 Jan 8:1-30. doi: 10.1080/13548506.2025.2606183. Online ahead of print.ABSTRACTIndividuals with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) frequently report […]
Wheat and chaff in Myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS) in clinics and laboratory
on 9 janvier 2026
J Transl Med. 2026 Jan 5;24(1):20. doi: 10.1186/s12967-025-07397-z.NO ABSTRACTPMID:41491817 | DOI:10.1186/s12967-025-07397-z
Theoretical foundation of the Activity Calculator - a method for fatigue management
on 9 janvier 2026
Scand J Occup Ther. 2025 Jan;32(1):2608471. doi: 10.1080/11038128.2025.2608471. Epub 2025 Dec 31.ABSTRACTBACKGROUND: Chronic fatigue impacts individuals' ability to engage in daily activities and […]
Age-specific alterations of the gut mycobiome in patients with myalgic encephalomyelitis/chronic fatigue syndrome and identification of potential diagnostic biomarkers
on 9 janvier 2026
BMC Microbiol. 2025 Dec 30. doi: 10.1186/s12866-025-04650-9. Online ahead of print.NO ABSTRACTPMID:41469536 | DOI:10.1186/s12866-025-04650-9
Comparative efficacy of various exercise therapies for chronic fatigue syndrome: A systematic review and network meta-analysis
on 9 janvier 2026
iScience. 2025 Nov 21;28(12):114178. doi: 10.1016/j.isci.2025.114178. eCollection 2025 Dec 19.ABSTRACTTo systematically compare the effectiveness of different exercise therapies for chronic fatigue […]
Sustained illness burden over time among Australians with myalgic encephalomyelitis/chronic fatigue syndrome
on 9 janvier 2026
PLoS One. 2025 Dec 29;20(12):e0338433. doi: 10.1371/journal.pone.0338433. eCollection 2025.ABSTRACTBACKGROUND: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a disabling chronic […]
Chronic Reactivation of Persistent Human Herpesviruses EBV, HHV-6 and VZV and Heightened Anti-dUTPase IgG Antibodies Are a Recurrent Hallmark in Post-Infectious ME/CFS and is Associated With Fatigue
on 9 janvier 2026
J Med Virol. 2026 Jan;98(1):e70769. doi: 10.1002/jmv.70769.ABSTRACTMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating disease with unknown etiology and heterogeneous […]
Histone phosphorylation analysis of two main TCM syndromes of chronic fatigue syndrome
on 9 janvier 2026
J Transl Med. 2025 Dec 25. doi: 10.1186/s12967-025-07579-9. Online ahead of print.ABSTRACTOBJECTIVE: This study aimed to investigate differences in protein expression, protein function, and […]
Diagnosis of chronic fatigue syndrome using beat-to-beat autonomic measurements
on 9 janvier 2026
J Transl Med. 2025 Dec 23;23(1):1413. doi: 10.1186/s12967-025-07433-y.ABSTRACTBACKGROUND: An artificial intelligence (AI) pipeline was used to differentiate patients suffering from Chronic Fatigue […]
Mapping the complexity of ME/CFS: Evidence for abnormal energy metabolism, altered immune profile, and vascular dysfunction
on 9 janvier 2026
Cell Rep Med. 2025 Dec 16;6(12):102514. doi: 10.1016/j.xcrm.2025.102514.ABSTRACTMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disorder with undefined mechanisms, no […]
How pandemics reshape our brain: Common links and targets between long-haul COVID-19, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), oxidative stress, and neurodegeneration
on 9 janvier 2026
Neuroprotection. 2025 May 29;3(3):280-287. doi: 10.1002/nep3.70007. eCollection 2025 Sep.ABSTRACTFatiguing syndromes affect millions of patients in the United States and globally, but are grossly […]
Heightened prevalence of chronic fatigue syndrome in U.S. sexual minorities
on 9 janvier 2026
J Psychiatr Res. 2025 Dec 11;193:468-471. doi: 10.1016/j.jpsychires.2025.12.024. Online ahead of print.ABSTRACTPURPOSE: To assess the prevalence and odds of chronic fatigue syndrome (CFS) among […]
Alterations in gut microbiota and associated metabolites in patients with chronic fatigue syndrome
on 9 janvier 2026
Sci Rep. 2025 Dec 12;15(1):43681. doi: 10.1038/s41598-025-27564-y.ABSTRACTTo investigate differences in gut microbiota composition and short-chain fatty acids (SCFAs) metabolism between patients with […]
Abnormal T-Cell activation and cytotoxic T-Cell frequency discriminate symptom severity in myalgic encephalomyelitis/chronic fatigue syndrome
on 9 janvier 2026
J Transl Med. 2025 Dec 10. doi: 10.1186/s12967-025-07507-x. Online ahead of print.ABSTRACTBACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating but […]
Virus Genome Sequences in the Blood of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
on 5 Décembre 2025
medRxiv [Preprint]. 2025 Nov 7:2025.11.06.25339689. doi: 10.1101/2025.11.06.25339689.ABSTRACTMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a baffling disease. The disease has a wide […]

CCAI

ccai_gen via biblio.chum on Inoreader

Progress Toward Understanding Infection-Associated Chronic Conditions and Illnesses - PubMed
on 6 février 2026
Display options Format AbstractPubMedPMID No abstract available Keywords: COVID-19; IACCI; Infection-associated chronic conditions and infections; Long COVID; bacteria; chronic fatigue syndrome; […]
Long COVID as an Infection-Associated Chronic Condition: Implications
on 6 février 2026
Am J Health Promot. 2025 Jul;39(6):960-965. doi: 10.1177/08901171241308066b. Epub 2025 Jun 8.ABSTRACTA link between infection and chronic illness has been recognized, along with the complexities of […]

Études cliniques

ccai_etudes_cliniques via biblio.chum on Inoreader

Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
on 6 février 2026
Conditions: Post-Acute COVID-19 Syndrome Interventions: Drug: Keytruda Sponsors: National Institute of Neurological Disorders and Stroke (NINDS) Not yet recruiting
Stellate Ganglion Block for Long COVID Symptoms: A Randomized Controlled Trial
on 6 février 2026
Conditions: Long COVID Interventions: Procedure: Stellate Ganglion Block (Bupivacaine); Procedure: placebo saline injection Sponsors: Centre intégré universitaire de santé et de services sociaux […]
Expanded Access Use of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Chronic Fatigue of Post-COVID Condition
on 6 février 2026
Conditions: Post-COVID-19 Condition; Post-COVID Condition; Post-COVID Syndrome; Long COVID; Chronic Fatigue; Chronic Fatigue Symptoms; Fatigue Post Viral Interventions: Biological: REGENECYTE® […]
Long COVID Diagnostic Reactivity Assesment Test
on 6 février 2026
Conditions: Long COVID; Post-Acute Sequelae of SARS-CoV-2 Infection Interventions: Diagnostic Test: Electrodiagnostic Bioelectrical Assessment Sponsors: Oncology Center,Ministry Of Heath,Uzbekistan […]
Immunoadsorption in Patients With Chronic Fatigue Syndrome Including Patients With Post-COVID-19 CFS
on 6 février 2026
Conditions: ME/CFS; Post-COVID ME/CFS Interventions: Device: Immunoadsorption Sponsors: Charite University, Berlin, Germany Completed
Second Prospective Cohort of Patients Entering the Multidisciplinary Care Pathway for Post-Covid Syndromes - SyPoCo2 Cohort
on 6 février 2026
Conditions: Post-Acute COVID-19 Syndrome Interventions: Other: Blood sample collection Sponsors: Hospices Civils de Lyon Recruiting
The Effect of Acupuncture Treatment on Cognitive Functions and Brain Networks for Long COVID
on 6 février 2026
Conditions: Long Covid Interventions: Other: Acupuncture; Other: Sham acupuncture Sponsors: Tingting Luo Not yet recruiting
sElective Serotonin reuPtake inhibitoRs In posT-covid
on 6 février 2026
Conditions: Post-COVID; POST-Covid 19; Post-COVID Conditions Interventions: Drug: Fluvoxamine; Drug: Placebo Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Not yet […]
Rehabilitation of Fatigue in Patients With Post-COVID-19 Syndrome
on 6 février 2026
Conditions: Post-COVID-19 Syndrome Interventions: Behavioral: Rehabilitation; Behavioral: Virtual reality based rehabilitation Sponsors: Universidad de Granada Completed
Acupuncture and Chinese Herbal Medicine for Long COVID
on 9 janvier 2026
Conditions: Long COVID Interventions: Procedure: Acupuncture Sponsors: Southern California University of Health Sciences Recruiting
Predictors of Long-Term Evolution in Long COVID; 4-Year Follow-Up. (BioICOPER Follow-up Study)
on 9 janvier 2026
Conditions: Persistent COVID Condition Interventions: Other: BioICOPER Long COVID Cohort Sponsors: Instituto de Investigación Biomédica de Salamanca; Carlos III Health Institute Not yet […]
Sonlicromanol in Post-COVID: A Randomized, Double-blind, Placebo-controlled, Phase II Trial
on 9 janvier 2026
Conditions: Post COVID Condition Interventions: Drug: Sonlicromanol; Drug: Placebo Sponsors: Michele van Vugt; ZonMw: The Netherlands Organisation for Health Research and Development; Khondrion BV […]
Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID?
on 9 janvier 2026
Conditions: Long COVID Syndrome Interventions: Dietary Supplement: Taurine supplementation Sponsors: York University; Long COVID Web; Canadian Institutes of Health Research (CIHR) Not yet […]
Whole-Body Electrostimulation for Functional Recovery in Post-COVID Syndrome
on 9 janvier 2026
Conditions: Post COVID Syndrome Long Covid; Post COVID Syndrome; Long COVID Fatigue; Long Covid Interventions: Device: Whole-Body Electromyostimulation Suit Sponsors: Universidad Rey Juan Carlos […]
The Effect of the Human Regenerator Jet Device on the Quality of Life of Adult Individuals [HR-QoL]
on 9 janvier 2026
Conditions: Chronic Stress; Chronic Fatigue; Chronic Pain; Post-COVID / Long-COVID Interventions: Device: Cold Atmospheric Plasma; Device: Atmospheric Air Sponsors: University of Athens; THE […]
Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2
on 9 janvier 2026
Conditions: PASC Post Acute Sequelae of COVID 19; Fatigue Interventions: Behavioral: Physical Fatigue Sponsors: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; National Institute of […]
RECLAIM Adaptive Platform Trial for PCC Treatments
on 9 janvier 2026
Conditions: Post COVID Condition Interventions: Drug: Metformin; Drug: colchicine Sponsors: Janneke van de Wijgert; European Clinical Research Alliance for Infectious Diseases (ECRAID) Enrolling […]
IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION
on 9 janvier 2026
Conditions: Myocarditis; Heart Failure; Myocardial Fibrosis; Vascular Inflammation; Long COVID Syndrome Interventions: Diagnostic Test: Cardiac Imaging Sponsors: Johann Wolfgang Goethe University […]
Brain Stimulation in Long COVID
on 9 janvier 2026
Conditions: Long COVID; PASC Post Acute Sequelae of COVID 19; Post COVID-19 Condition (PCC) Interventions: Device: Repetitive Transcranial Magnetic Stimulation; Device: Sham device Sponsors: […]
Immunoadsorption in Autoimmune Long COVID
on 9 janvier 2026
Conditions: Long COVID; Long COVID Syndrome; Long COVID-19 Syndrome; Post COVID Syndrome Interventions: Device: Immunoadsorption; Device: Sham Comparator Sponsors: Academisch Medisch Centrum - […]

Formation continue

ccai_formation_continue via biblio.chum on Inoreader

2026_Program_LTBDI_Symposium.pdf
on 6 février 2026
Looking at the Pandemic in the Rearview Mirror: Successes, Failures and Unintended Consequences. Conference, May 2025.
on 6 février 2026
Supporting the generation of high-quality evidence for public health emergencies. Fostering effective and efficient knowledge exchange for global public health emergencies. Inspiring policymakers […]
2026 International Forum on COVID Rehabilitation Research
on 6 février 2026
Rob Wüst is an Associate Professor at the Faculty of Behavioral and Movement Sciences at the Vrije Universiteit Amsterdam. His research group studies skeletal and cardiac muscle metabolism and […]
2026 Symposium
on 6 février 2026
Long Covid Web and the University of British Columbia are pleased to announce the 2026 Canadian Symposium on Long COVID. The Symposium will bring together people with lived experience of Long COVID, […]

Revue d'actualités

ccai_actualites via biblio.chum on Inoreader

Biting back at Lyme disease
on 6 février 2026
Nat Med. 2026 Jan 6. doi: 10.1038/d41591-026-00001-x. Online ahead of print.NO ABSTRACTPMID:41495451 | DOI:10.1038/d41591-026-00001-x
NHS Highland to offer virtual chronic fatigue syndrome service - BBC
on 6 février 2026
NHS Highland to offer virtual chronic fatigue syndrome service BBC
Décryptage : Covid long et troubles menstruels - Centre national de la recherche scientifique (CNRS)
on 6 février 2026
Décryptage : Covid long et troubles menstruels Centre national de la recherche scientifique (CNRS)
A Letter from John Aucott, MD : Johns Hopkins Lyme Disease Research Center
on 9 janvier 2026
The December 15, 2025 Health and Human Services (HHS) “Invisible Illness” Lyme Disease Roundtable marked a pivotal federal acknowledgment that Lyme disease is a serious, chronic, biologically […]
Biting back at Lyme disease
on 9 janvier 2026
Nat Med. 2026 Jan 6. doi: 10.1038/d41591-026-00001-x. Online ahead of print.NO ABSTRACTPMID:41495451 | DOI:10.1038/d41591-026-00001-x
Researchers identify viral suspects that could be fueling long COVID - ScienceDaily
on 9 janvier 2026
Researchers identify viral suspects that could be fueling long COVID ScienceDaily
Resistance Training Improves Long COVID Outcomes
on 5 Décembre 2025
JAMA. 2025 Nov 21. doi: 10.1001/jama.2025.19746. Online ahead of print.NO ABSTRACTPMID:41269680 | DOI:10.1001/jama.2025.19746
U of A research explores reasons for higher long-COVID rate among women - CTV News
on 5 Décembre 2025
U of A research explores reasons for higher long-COVID rate among women CTV News
8 trajectories for long COVID - Harvard Gazette
on 3 Décembre 2025
8 trajectories for long COVID Harvard Gazette
Why women may experience long COVID at a higher rate than men - CTV News
on 3 Décembre 2025
Why women may experience long COVID at a higher rate than men CTV News
Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous disease - The Lancet
on 3 Décembre 2025
Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous disease The Lancet
Valneva annonce des résultats finaux positifs de Phase 2 pour son candidat vaccin contre la maladie de Lyme - lesoleil.com
on 3 Décembre 2025
Valneva annonce des résultats finaux positifs de Phase 2 pour son candidat vaccin contre la maladie de Lyme lesoleil.com
Why is ‘chronic’ lyme disease so controversial? – podcast
on 7 novembre 2025
Long COVID is here to stay—even in children - The Lancet
on 7 novembre 2025
Long COVID is here to stay—even in children The Lancet
New research sheds light on why brain fog is a common symptom of long COVID. - Psychology Today
on 7 novembre 2025
New research sheds light on why brain fog is a common symptom of long COVID. Psychology Today
Scientists may have discovered what’s behind long COVID-related brain fog - Toronto Star
on 7 novembre 2025
Scientists may have discovered what’s behind long COVID-related brain fog Toronto Star
Vivre avec la COVID longue : une exposition donne la parole aux malades - Radio-Canada
on 7 novembre 2025
Vivre avec la COVID longue : une exposition donne la parole aux malades Radio-Canada
Enfin de l’espoir pour le syndrome de fatigue chronique - Le Devoir
on 7 novembre 2025
Enfin de l’espoir pour le syndrome de fatigue chronique Le Devoir
Lyme disease: 'My independence is gone completely' after tick bite - BBC
on 6 octobre 2025
Lyme disease: 'My independence is gone completely' after tick bite BBC
RFK Jr. nomme un chercheur controversé à la tête d’un comité sur la COVID longue - Radio-Canada
on 3 octobre 2025
RFK Jr. nomme un chercheur controversé à la tête d’un comité sur la COVID longue Radio-Canada

Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.

Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.

Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.

Avis de non-responsabilité

1. EXCLUSION DE GARANTIES ET LIMITATION DE RESPONSABILITÉ

Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit.

Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.

2. RESPONSABILITÉ RELATIVES AUX LIENS

Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées.

Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.

3. PROPRIÉTÉ INTELLECTUELLE

Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42).

Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité.

Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables.